Torys LLP acted as counsel to Maverix on the deal. On April 12, 2022, Viral Nation Inc. announced an initial funding round of C$250 million led by...
Viral Nation’s C$250 Million Financing Round
Parkland’s C$322 Million Acquisition of M&M Food Market
Torys LLP acted as counsel to Parkland in connection with the acquisition of M&M Food Market. Parkland Corporation has entered an agreement to acquire M&M Food...
LQT Therapeutics’ $19 Million Series A Financing
Torys LLP represented Amplitude Ventures in the financing. On August 10, 2021, LQT Therapeutics, Inc. completed a US$19 million Series A financing. The financing was led by...
IntelGenx’s Strategic Partnership with atai Life Sciences
Torys LLP represented atai on the deal. McCarthy Tetrault LLP assisted IntelGenx . On May 14, 2021, IntelGenx Technologies Corp. (“IntelGenx”), a leader in pharmaceutical films completed...
Alpha-9 Theranostics’ C$11 Million Series A Financing
Torys LLP represented Longitude Capital on the transaction. On April 28, 2021, Alpha-9 Theranostics Inc. announced an C$11 million Series A financing to advance a portfolio...
Cardiol Therapeutics’ C$22 Million Bought Deal Offering
Torys LLP represented the syndicate of underwriters in connection with Cardiol Therapeutics offering. On May 12, 2021, Cardiol Therapeutics Inc. announced its completed bought deal public...
Dejero Labs Inc.’s C$60 Million Recapitalization
Torys LLP acted for Vertu Capital. On April 21, 2021, Dejero Labs Inc. announced a C$60 million minority recapitalization of the business led by Vertu Capital,...